UFP Technologies, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
UFP Technologies, Inc. (UFPT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 0.30% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-03-03
- UFP Technologies, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 0.30%, a 200.00% increase from fiscal 2023.
- UFP Technologies, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 0.10%, a 85.71% decline from fiscal 2022.
- UFP Technologies, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 0.70%, a 58.82% decline from fiscal 2021.
- UFP Technologies, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 1.70%, a 76.39% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2024-12-31 | 0.30% 10-K · filed 2025-03-03 |
| 2023-12-31 | 0.10% 10-K · filed 2025-03-03 |
| 2022-12-31 | 0.70% 10-K · filed 2025-03-03 |
| 2021-12-31 | 1.70% 10-K · filed 2024-02-29 |
| 2020-12-31 | 7.20% 10-K · filed 2023-03-16 |
| 2019-12-31 | 6.20% 10-K · filed 2022-03-14 |
| 2018-12-31 | 1.90% 10-K · filed 2021-03-12 |
| 2017-12-31 | 0.60% 10-K · filed 2020-03-13 |
| 2016-12-31 | 0.60% 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |